SCHEMBL904217

SCHEMBL904217

Nc1nc(C(=O)N2Cc3ccccc3C2)c2cc(-c3ccccc3CN(CCO)CCO)ccc2n1

nearest known ligand 0.78

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 12/20 0.78
HSP90AB1 P08238 4/20 0.57
F10 P00742 1/20 0.38
MGLL Q99685 1/20 0.33
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KDM4E B2RXH2 1/20 0.32
HTT P42858 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CYP1A2 P05177 3/20 0.32
CYP3A4 P08684 3/20 0.32
CYP2D6 P10635 3/20 0.32
CLK4 Q9HAZ1 2/20 0.32
DHFR P00374 1/20 0.32
CYP2C19 P33261 2/20 0.32
ALDH1A1 P00352 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL904234 0.95 HSP90AA1 (0.73) HSP90AA1HSP90AB1F10ALDH1A1
SCHEMBL10255013 0.92 HSP90AA1 (0.77) HSP90AA1HSP90AB1CYP1A2CYP3A4CYP2D6
SCHEMBL904221 0.90 HSP90AA1 (0.76) HSP90AA1HSP90AB1F10DHFRALDH1A1
SCHEMBL13144879 0.88 HSP90AA1 (0.79) HSP90AA1HSP90AB1HPGDSMN1; SMN2KDM4E
SCHEMBL904228 0.88 HSP90AA1 (1.00) HSP90AA1HSP90AB1MGLLHPGDSMN1; SMN2
SCHEMBL10254791 0.87 HSP90AA1 (0.64) HSP90AA1HSP90AB1ALDH1A1
SCHEMBL904218 0.86 HSP90AA1 (0.76) HSP90AA1HSP90AB1CYP1A2CYP3A4CYP2D6
SCHEMBL10254642 0.86 HSP90AA1 (0.61) HSP90AA1HSP90AB1ALDH1A1
SCHEMBL3095988 0.86 HSP90AA1 (0.85) HSP90AA1HSP90AB1KDM4EHTTNPSR1
SCHEMBL13144793 0.86 HSP90AA1 (0.85) HSP90AA1HSP90AB1HPGDSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791129-B2 Phenylquinazoline derivatives MERCK PATENT GMBH (DE) 2014-07-29 US disclosed
US-8791129-B2 Phenylquinazoline derivatives MERCK PATENT GMBH (DE) 2014-07-29 US disclosed
US-8791129-B2 Phenylquinazoline derivatives MERCK PATENT GMBH (DE) 2014-07-29 US disclosed
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-07-11 US disclosed
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-07-11 US disclosed
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-07-11 US disclosed
WO-2012041435-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES HSP90B1, HSP90AB1, HSP90AA1 HSP90AA1 3/4885HSP90AB1 2/4885F10 3556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.